| JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas O Mariani, C Brennetot, JM Coindre, N Gruel, C Ganem, O Delattre, ... Cancer cell 11 (4), 361-374, 2007 | 251 | 2007 |
| Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity A Vincent-Salomon, N Gruel, C Lucchesi, G MacGrogan, R Dendale, ... Breast Cancer Research 9 (2), R24, 2007 | 239 | 2007 |
| High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors E Manié, A Vincent-Salomon, J Lehmann-Che, G Pierron, E Turpin, ... Cancer research 69 (2), 663-671, 2009 | 209 | 2009 |
| Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast A Vincent-Salomon, C Lucchesi, N Gruel, V Raynal, G Pierron, ... Clinical cancer research 14 (7), 1956-1965, 2008 | 195 | 2008 |
| Transcriptional programs define intratumoral heterogeneity of Ewing sarcoma at single-cell resolution MM Aynaud, O Mirabeau, N Gruel, S Grossetête, V Boeva, S Durand, ... Cell reports 30 (6), 1767-1779. e6, 2020 | 167 | 2020 |
| 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis S Rodrigues-Ferreira, A Di Tommaso, A Dimitrov, S Cazaubon, N Gruel, ... PloS one 4 (10), e7239, 2009 | 121 | 2009 |
| VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles PL Rosa, E Viara, P Hupe, G Pierron, S Liva, P Neuvial, I Brito, S Lair, ... Bioinformatics 22 (17), 2066-2073, 2006 | 119 | 2006 |
| Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer I Bernard-Pierrot, N Gruel, N Stransky, A Vincent-Salomon, F Reyal, ... Cancer research 68 (17), 7165-7175, 2008 | 113 | 2008 |
| Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments C Caron de Fromentel, N Gruel, C Venot, L Debussche, E Conseiller, ... Oncogene 18 (2), 551-557, 1999 | 113 | 1999 |
| A prognostic DNA signature for T1T2 node‐negative breast cancer patients E Gravier, G Pierron, A Vincent‐Salomon, N Gruel, V Raynal, A Savignoni, ... Genes, chromosomes and cancer 49 (12), 1125-1134, 2010 | 112 | 2010 |
| ESR1 gene amplification in breast cancer: a common phenomenon? JS Reis-Filho, S Drury, MB Lambros, C Marchio, N Johnson, R Natrajan, ... Nature genetics 40 (7), 809-810, 2008 | 112 | 2008 |
| CXCR6 expressing T cells: Functions and role in the control of tumors N Mabrouk, T Tran, I Sam, I Pourmir, N Gruel, C Granier, J Pineau, A Gey, ... Frontiers in immunology 13, 1022136, 2022 | 107 | 2022 |
| Polarity gene alterations in pure invasive micropapillary carcinomas of the breast N Gruel, V Benhamo, J Bhalshankar, T Popova, P Fréneaux, L Arnould, ... Breast Cancer Research 16 (3), R46, 2014 | 107 | 2014 |
| A siRNA screen identifies RAD21 , EIF3H , CHRAC1 and TANC2 as driver genes within the 8q23, 8q24 … SF Mahmood, N Gruel, E Chapeaublanc, A Lescure, T Jones, F Reyal, ... Carcinogenesis 35 (3), 670-682, 2014 | 96 | 2014 |
| Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis M Wassef, V Rodilla, A Teissandier, B Zeitouni, N Gruel, B Sadacca, ... Genes & development 29 (24), 2547-2562, 2015 | 95 | 2015 |
| Gene expression profiling of 1p35–36 genes in neuroblastoma I Janoueix-Lerosey, E Novikov, M Monteiro, N Gruel, G Schleiermacher, ... Oncogene 23 (35), 5912-5922, 2004 | 93 | 2004 |
| CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors S Karaki, C Blanc, T Tran, I Galy-Fauroux, A Mougel, E Dransart, M Anson, ... Journal for ImmunoTherapy of Cancer 9 (3), e001948, 2021 | 78 | 2021 |
| ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics A Molina, L Velot, L Ghouinem, M Abdelkarim, BP Bouchet, AC Luissint, ... Cancer research 73 (9), 2905-2915, 2013 | 77 | 2013 |
| Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma C Thirant, A Peltier, S Durand, A Kramdi, C Louis-Brennetot, ... Nature communications 14 (1), 2575, 2023 | 76 | 2023 |
| Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma N Gruel, C Lucchesi, V Raynal, MJ Rodrigues, G Pierron, R Goudefroye, ... European Journal of Cancer 46 (13), 2399-2407, 2010 | 72 | 2010 |
